首页> 外文会议>IEEE Symposium on Ultrasonics >Status of piezoelectric single crystal growth for medical transducer applications
【24h】

Status of piezoelectric single crystal growth for medical transducer applications

机译:用于医用传感器应用的压电单晶生长状态

获取原文

摘要

Single crystal piezoelectrics such as PMN-PT are leading to dramatic improvements in transducer, sensor and actuator technology. The potential benefit of implementing these materials is clearly promising in terms of increased bandwidth, sensitivity and source levels due to ultrahigh electromechanical coupling factors (k/sub 33/94%), high piezoelectric coefficients (d/sub 33/2500pC/N), high strain levels (0.6%), and low hysteresis. TRS is investigating a variety of uses for piezoelectric single crystals in medical transducer applications such as ultrasound harmonic imaging and high frequency transducers. Harmonic imaging requires very broad bandwidth ultrasonic transducers. By using single crystals, which inherently have more bandwidth, the complex engineering normally associated with achieving increased bandwidth will be reduced. Simple ultrasound transducers that have been constructed from crystals exhibiting bandwidths of 100% (if high impedance, backing layers are used, 140% can be achieved) and insertion losses less than similarly constructed PZT transducers with only a 70% bandwidth. To date, commercialization of these materials for ultrasound has been limited by low yields, small size, and high cost. The primary cost driver for single crystals is the amount of useable material yielded per growth run. Currently these crystals are grown by the Bridgman method, which involves moving a crucible containing a molten charge relative to a stationary temperature gradient resulting in unidirectional solidification. One limiting factor of the Bridgman growth technique for PMN-PT is that useful compositions of this system have a segregation coefficient less than 1, so there is a significant compositional gradient along the growth axis, which severely limits the amount of crystal yielded per growth run. The current state of the art is Bridgman-grown 1.5-2" diameter boules. Scaling up and the use of zone melting in the Bridgman technique to increase useable length are expected to yield price reductions for large volume production that are 2 to 3 times that of high quality PZT ceramic (/spl sim/$20 to 30/cc). The current status of the growth development including current issues as well as preliminary results of utilizing crystals in medical transducer applications will be discussed.
机译:单晶压电等PMN-PT导致换能器,传感器和执行器技术的显着改善。实施这些材料的潜在益处在由于超高机电耦合因子(k / sub 33 / <94%),高压电系数(d / sub 33 / <2500pc / n)增加了增加的带宽,灵敏度和源极水平方面显然很有前途。 ),高应变水平(<0.6%)和低滞后。 TRS正在研究医疗传感器应用中的压电单晶的各种用途,例如超声谐波成像和高频换能器。谐波成像需要非常宽的带宽超声换能器。通过使用固有地具有更多带宽的单晶,将减少通常与实现增加的带宽相关联的复杂工程。已从表现出100%的带宽(如果高阻抗,用于背衬层,可达到140%)和插入损耗小于与只有70%的带宽类似构造的PZT换能器晶体构造简单超声换能器。迄今为止,这些超声波材料的商业化受低产率,小尺寸和高成本的限制。单晶的主要成本驱动器是每次生长所产生的可用材料的量。目前,这些晶体由Bridgman方法生长,这涉及相对于固定温度梯度移动含有熔融电荷的坩埚,导致单向凝固。对PMN-PT的Bridgman生长技术的一个限制因子是该系统的有用组合物的分离系数小于1,因此沿着生长轴存在显着的成分梯度,这严重限制了每次生长所产生的晶体量。本领域的当前状态是Bridgman-生长的1.5-2“直径槽。预计缩放和利用区域熔化的区域熔化以增加可用长度,将屈服于2〜3倍的大批量生产降价高质量的PZT陶瓷(/ SPL SIM / $ 20至30 / CC)。将讨论在医疗传感器应用中使用当前问题的增长开发的现状以及在医疗传感器应用中使用晶体的初步结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号